KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Other Operating Expenses: 2015-2024

Historic Other Operating Expenses for Medpace Holdings (MEDP) over the last 10 years, with Dec 2024 value amounting to $1.5 billion.

  • Medpace Holdings' Other Operating Expenses rose 27.02% to $463.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 11.53%. This contributed to the annual value of $1.5 billion for FY2024, which is 6.65% up from last year.
  • Per Medpace Holdings' latest filing, its Other Operating Expenses stood at $1.5 billion for FY2024, which was up 6.65% from $1.4 billion recorded in FY2023.
  • In the past 5 years, Medpace Holdings' Other Operating Expenses registered a high of $1.5 billion during FY2024, and its lowest value of $655.0 million during FY2020.
  • Its 3-year average for Other Operating Expenses is $1.3 billion, with a median of $1.4 billion in 2023.
  • Data for Medpace Holdings' Other Operating Expenses shows a peak YoY soared of 32.27% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Medpace Holdings' Other Operating Expenses stood at $655.0 million in 2020, then rose by 25.08% to $819.3 million in 2021, then climbed by 25.82% to $1.0 billion in 2022, then spiked by 32.27% to $1.4 billion in 2023, then increased by 6.65% to $1.5 billion in 2024.